HIGHFDA DRUG

Sucralfate Tablets Recalled by American Health Packaging for CGMP Deviations (27,868 Packs, 2025)

27,868 blister packs of Sucralfate Tablets, 1 g, distributed nationwide by American Health Packaging are recalled. The recall stems from CGMP deviations that prevent the firm from assuring product identity, strength, quality and purity. Health providers and consumers should stop using the product immediately and await guidance.

Official notice
SucralfateAmerican Health PackagingHealth & Personal CareDrugs & MedicationsLot #: 1017392 Exp 01/31/20261017415 Exp 12/31/2025

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
October 9, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
October 9, 2025
Hazard Level
HIGH
Brands
Sucralfate, American Health Packaging
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Sucralfate, American Health Packaging
Product type
Sucralfate Tablet, 1 g
Model numbers
Lot #: 1017392 Exp 01/31/2026, 1017415 Exp 12/31/2025
UPC codes
60687-695, 60687-695-11, 60687-695-01
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 9, 2025

  2. Reported by FDA DRUG

    October 22, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Sucralfate is used to treat active duodenal and gastric ulcers. The recalled product is an oral tablet issued Rx only and distributed nationwide. This recall centers on CGMP deviations, not on reported patient harm.

Why This Is Dangerous

CGMP deviations prevent the sponsor from ensuring the product’s identity, strength, quality and purity. The product is deemed adulterated under current manufacturing standards.

Industry Context

This recall is not presented as part of a broader industry pattern.

Real-World Impact

Patients relying on this therapy could be affected if the product does not meet quality standards. No injuries reported yet, but adulteration risk warrants stopping use and seeking guidance.

Practical Guidance

How to identify if yours is affected

  1. Check NDC on bottle: 60687-695-01
  2. Check carton NDC: 60687-695-11
  3. Identify Lot numbers: 1017392 or 1017415
  4. Check Expiration Dates: 01/31/2026 and 12/31/2025

Where to find product info

Recall letter and FDA enforcement page list affected lots and disposal/return instructions

What timeline to expect

Refunds or replacements, if offered, will be communicated via recall notification letter; no specific timeline published

If the manufacturer is unresponsive

  • File a formal complaint with the FDA if the company is unresponsive
  • Consult your pharmacist or physician for alternatives
  • Keep records of all correspondence

How to prevent similar issues

  • Always verify NDC numbers when dispensing or purchasing sucralfate
  • Ask for current lot numbers and expiration dates from pharmacies
  • Avoid purchasing recalled lots in the future; verify packaging before use

Documentation advice

Keep the recall notice, take photos of packaging, save purchase receipts, document lot numbers and expiration dates, log any adverse events

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Sucralfate Tablets, USP 1 g, 100 tablets, (10x10) Rx Only NDC: 60687-695-01 Carton NDC: 60687-695-11 Distributor: American Health Packaging, Columbus, OH 43217 Quantity recalled: 27,868 blister packs Distribution: Nationwide in the United States Recall date: 2025-10-09 Status: Active Brand: Sucralfate Lot numbers/Exp dates: Lot 1017392 — Exp 01/31/2026; Lot 1017415 — Exp 12/31/2025

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 27,868 blister packs affected
  • NDC 60687-695-01 on primary packaging
  • Lot numbers 1017392 and 1017415 with Expirations 01/31/2026 and 12/31/2025
  • Distributed nationwide in the United States
  • Recall status: Active

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #: 1017392 Exp 01/31/2026
1017415 Exp 12/31/2025
UPC Codes
60687-695
60687-695-11
60687-695-01
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

KVK-Tech Inc. Recalls Oxycodone Hydrochloride Tablets Over Seal Defects

KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.

OXYCODONE HYDROCHLORIDE
Defective container:
Read more